0000856982 false MERIT MEDICAL SYSTEMS INC 0000856982 2020-11-10 2020-11-10

​

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

​

FORM 8-K

​

CURRENT REPORT

​

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): November 10, 2020

​

​

Merit Medical Systems, Inc.

(Exact name of registrant as specified in its charter)

​

​ | ​ | ​ | ​ | ​
Utah |  | 0-18592 |  | 87-0447695
(State or other jurisdiction of | ​ | (Commission | ​ | (I.R.S. Employer
incorporation or organization) | ​ | File Number) | ​ | Identification No.)

​

​ | ​ | ​
1600 West Merit Parkway |  | ​
South Jordan, Utah | ​ | 84095
(Address of principal executive offices) | ​ | (Zip Code)

​

(801) 253-1600

(Registrant's telephone number, including area code)

​

N/A

(Former name or former address, if changed since last report)

​

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

​

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

​

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

​

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

​

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​

Securities registered pursuant to Section 12(b) of the Act:

​

Title of each class |  | Trading Symbol(s) |  | Name of each exchange on which registered
Common Stock, no par value | ​ | MMSI | ​ | NASDAQ Global Select Market System

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

​

Emerging growth company ☐

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

​

​

​

​

​

​

​

Item 7.01. Regulation FD Disclosure.

​

As previously announced, on November 10, 2020, Merit Medical Systems, Inc. (the “Company”) will hold a conference call and live webcast to introduce its projections for growth over the next three fiscal years and answer questions from participants on the call. In connection with that call, the Company issued a press release regarding its new multi-year financial targets for the period 2020 to 2023, which will be discussed during the investor call. The Company’s press release provides information regarding access to the call and webcast. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

​

In addition, on November 10, 2020, the Company has posted to its website the slide presentation that will be used during the call and webcast. A copy of the presentation is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

​

The Company is furnishing the information in this Item 7.01 (including the referenced exhibits attached hereto) pursuant to Regulation FD promulgated under the Exchange Act. Such information shall not be deemed “filed” for purposes of the Exchange Act or otherwise subject to the liabilities of that section, and is not deemed incorporated by reference into any filing under the Securities Act, except as expressly set forth by specific reference in such a filing.

​

​

2

​

Item 9.01. Financial Statements and Exhibits.

​

(d)Exhibits

​

Exhibit No. | Exhibit
99.1 ​ | Press Release, dated November 10, 2020, entitled “Merit Medical to Present ‘Foundations for Growth’ Program and Financial Targets for 2020 to 2023.”
99.2 ​ | Conference Call Presentation
101 | The cover page from this Current Report on Form 8-K, formatted in Inline XBRL and incorporated as Exhibit 101 ​
104 | The cover page from this Current Report on Form 8-K, formatted in Inline XBRL. ​

​

3

​

SIGNATURES

​

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

​

​ | MERIT MEDICAL SYSTEMS, INC.
​ | ​ | ​
​ | ​ | ​
Date: November 10, 2020 | By: | /s/ Brian G. Lloyd
​ | ​ | Brian G. Lloyd
​ | ​ | Chief Legal Officer and Corporate Secretary

​

​

4